FOLICRON SR Sustained-release Tablet
Ferrous sulfate dried, Folic acid
150 mg + 0.5 mg
Gulf Pharmaceutical Industries (Julphar)
| Pack size | 30's Pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 0.23 AED |
Indications
FOLICRON SR Sustained-release Tablet is used for:
IRON
Used in preventing and treating iron-deficiency anemia
Used in preventing and treating iron-deficiency anemia
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Ferrous sulfate dried, Folic acid :
Mechanism of Action
IRON
Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia
Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia
Note
FOLICRON SR 150 mg + 0.5 mg Sustained-release Tablet manufactured by Gulf Pharmaceutical Industries (Julphar). Its generic name is Ferrous sulfate dried, Folic acid. FOLICRON SR is availble in Saudi Arabia.
Farmaco SA drug index information on FOLICRON SR Sustained-release Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.